SEC Form 4 · accession 0001553878-16-000046
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marsha Fanucci
Director
Period of report
Jun 3, 2016
Accepted (ET)
Jun 7, 2016 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $70.20 | Jun 3, 2016 | A | 11,250 | A | Jun 3, 2017 | Jun 3, 2026 | Common Stock | 11,250 | 11,250 | D |